Canada became the first country in the world that has authorized the use of a plant-based COVID-19 vaccine. The two-dose vaccine of Medicago Inc. (a biopharma company owned by Mitsubishi Chemical and Philip Morris), can be given to adults who are aged between 18 to 64, but little data is available on the shots received by people aged 65 and above.
Buy Prime Test Series for all Banking, SSC, Insurance & other exams
The decision to authorize the vaccine was based on a study conducted on 24,000 adults that showed the efficacy rate of the vaccine is 71% at preventing COVID-19 – although the tests were conducted before the omicron variant emerged. Covifenz is the name given to this vaccine. Canada agreed to buy 20 million doses of this plant-based vaccine, with an option to purchase 56 million additional doses.
Important takeaways for all competitive exams:
Chinese human-like robots have attracted attention following their participation in a 100-meter dash event where…
The Onam festival of 2026 is being celebrated throughout the state of Kerala through colorful…
The US government has unveiled an operation called Economic Outcast, which is a new global…
The National Security Guard (NSG) has inaugurated the first-ever Mahila Commando Conversion Course (MCCC) at…
National Conclave on Tribal Languages and Museums was launched in the Mysuru, Karnataka, on August…
As per a recent report released by NITI Aayog, close to 8.7 crore Indians between…